These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 36862204)

  • 1. A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment.
    Dillemans L; De Somer L; Neerinckx B; Proost P
    Cell Mol Life Sci; 2023 Mar; 80(3):78. PubMed ID: 36862204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
    Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
    J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis.
    Loos T; Dekeyzer L; Struyf S; Schutyser E; Gijsbers K; Gouwy M; Fraeyman A; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J; Proost P
    Lab Invest; 2006 Sep; 86(9):902-16. PubMed ID: 16847431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
    Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
    Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M; Carter S; Hofer MJ; Campbell IL
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
    Aggarwal A; Agarwal S; Misra R
    Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
    Xanthou G; Duchesnes CE; Williams TJ; Pease JE
    Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
    Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
    Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.
    Metzemaekers M; Vanheule V; Janssens R; Struyf S; Proost P
    Front Immunol; 2017; 8():1970. PubMed ID: 29379506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis
    Liu QZ; Ma WT; Yang JB; Zhao ZB; Yan K; Yao Y; Li L; Miao Q; Gershwin ME; Lian ZX
    Front Immunol; 2018; 9():1090. PubMed ID: 29868034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
    Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
    Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N
    Front Immunol; 2020; 11():976. PubMed ID: 32547545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
    Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
    J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
    Proost P; Struyf S; Loos T; Gouwy M; Schutyser E; Conings R; Ronsse I; Parmentier M; Grillet B; Opdenakker G; Balzarini J; Van Damme J
    Arthritis Res Ther; 2006; 8(4):R107. PubMed ID: 16846531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis.
    Singh UP; Singh R; Singh S; Karls RK; Quinn FD; Taub DD; Lillard JW
    BMC Immunol; 2008 Jun; 9():25. PubMed ID: 18533024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
    J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment.
    Reynders N; Abboud D; Baragli A; Noman MZ; Rogister B; Niclou SP; Heveker N; Janji B; Hanson J; Szpakowska M; Chevigné A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31216755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
    Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
    J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
    Balashov KE; Rottman JB; Weiner HL; Hancock WW
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.